<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457766</url>
  </required_header>
  <id_info>
    <org_study_id>HIFU in skin cancers</org_study_id>
    <nct_id>NCT03457766</nct_id>
  </id_info>
  <brief_title>Presurgical Evaluation of Skin Cancers Using HIFU</brief_title>
  <official_title>Presurgical Evaluation of Nonmelanoma Skin Cancers Using High Frequency Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To ensure complete elimination of lesions with maximum preservation of function and
           aesthetics.

        2. To elaborate the Ultrasonographic features of skin cancers.

        3. To determine the accuracy of HIFU to assess the margins of skin lesions and its safety
           margins by histopathiological examination..

        4. To follow up the patient postoperatively for incomplete excision or recurrence by
           clinical and HIFU examination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The skin is the most superficial and largest body organ, due to its function as a surface
      covering for the body, enables the performance of noninvasive diagnostic and investigative
      procedures.

      Of all the tumors that affect humans, non-melanoma cutaneous cancer is the most common e.g.
      basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

      Techniques such as high frequency ultrasound (HFUS) enable the real-time study of cutaneous
      lesions, making them excellent pre-operative tools varying considerably in their penetration,
      resolution, and applicability.

      High frequency ultrasound has been used in dermatology since the 1970s, ultrasonography is a
      painless non-radioactive imaging diagnostic method based on the reflection of sound waves
      through body tissues.

      High frequency ultrasound allows for the delimiting of the margins of the neoplasia, due to
      the difference in echogenicity between the hypoechoic tumoral area and the hyperechoic
      perilesional area.

      High frequency ultrasound examination of each lesion should consist of:

        1. A morphologic study analyzing the structural sonographic pattern and margins;

        2. the measurement of the largest transverse diameter and thickness;

        3. Color Doppler USG for perilesional vessels ; and

        4. in cases suspicious for malignancy, the surrounding areas are scanned for locoregional
           metastasis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Using high frequency ultrasound in identification of safety margins of skin cancers</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete excision of nonmelanoma skin cancers</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination the accuracy of HIFU to assess the margins of skin lesions and its safety margins to ensure complete elimination of lesions with maximum preservation of function and aesthetics</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Skin Cancer, Non-Melanoma</condition>
  <arm_group>
    <arm_group_label>Patients with skin lesions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using HIFU in identification of safety margins of lesions clinically apparent locally malignant, or malignant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HIFU</intervention_name>
    <description>Ultrasound (Esaota MyLabSeven) imaging system using (SL2325) probe with (6-19 MHz) frequency</description>
    <arm_group_label>Patients with skin lesions</arm_group_label>
    <other_name>Esaota MyLabSeven</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 30 &amp; 80 years.

          -  Lesions clinically apparent locally malignant, or malignant.

          -  Lesions with or without visible ulcerations.

        Exclusion Criteria:

          -  Surgeon unable to visualize tumor on clinical examination.

          -  Patients unfit for surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mostafa AH El-Sonbaty, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>George G Gergis, Doctorate</last_name>
    <phone>+2 0100-099-8748</phone>
    <email>georgegamil.plastic@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed MA Tohamy, Professor</last_name>
    <phone>+2 0100-266-0832</phone>
    <email>ahmedtohamy92@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008 Dec;17(12):1063-72. Review.</citation>
    <PMID>19043850</PMID>
  </reference>
  <reference>
    <citation>Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014 Mar 1;383(9919):816-27. doi: 10.1016/S0140-6736(13)60802-8. Epub 2013 Sep 19. Review.</citation>
    <PMID>24054424</PMID>
  </reference>
  <reference>
    <citation>Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010 Feb 20;375(9715):673-85. doi: 10.1016/S0140-6736(09)61196-X.</citation>
    <PMID>20171403</PMID>
  </reference>
  <reference>
    <citation>Kleinerman R, Whang TB, Bard RL, Marmur ES. Ultrasound in dermatology: principles and applications. J Am Acad Dermatol. 2012 Sep;67(3):478-87. doi: 10.1016/j.jaad.2011.12.016. Epub 2012 Jan 30. Review.</citation>
    <PMID>22285673</PMID>
  </reference>
  <reference>
    <citation>Bobadilla F, Wortsman X, Mu√±oz C, Segovia L, Espinoza M, Jemec GB. Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology. Cancer Imaging. 2008 Sep 22;8:163-72. doi: 10.1102/1470-7330.2008.0026.</citation>
    <PMID>18812268</PMID>
  </reference>
  <reference>
    <citation>Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002 Apr;146 Suppl 61:1-6. Review.</citation>
    <PMID>11966724</PMID>
  </reference>
  <reference>
    <citation>Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH, Neumann HA. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face. Arch Dermatol. 2006 Feb;142(2):187-94.</citation>
    <PMID>16490846</PMID>
  </reference>
  <reference>
    <citation>Ansarin H, Daliri M, Soltani-Arabshahi R. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma. Eur J Dermatol. 2006 Sep-Oct;16(5):543-7.</citation>
    <PMID>17101476</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>George Gamil Gergis</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

